You appear to be offline. Some data may be unavailable until your connection is restored.

RMD

Stock

Resmed Inc

Create price alert
$238.89
+$1.02 (0.43%)
At close: Nov 12, 2026, 4:00 PM

Description

ResMed Inc. designs, manufactures and markets equipment for diagnosing and treating sleep‑disordered breathing and other respiratory conditions, including CPAP and bilevel positive‑airway‑pressure machines, masks, home ventilators and related consumables. The company also provides cloud‑based software platforms that enable remote patient monitoring, data analytics and workflow management for sleep clinics, home‑care providers and other healthcare professionals. Operating in the medical‑technology, sleep health and digital‑health sectors, ResMed is recognized as the global leader in the sleep‑apnea device market and serves customers in more than 140 countries. Its business model blends a “razor‑and‑blade” approach—device sales paired with recurring revenue from mask and accessory replacements—with a growing SaaS component that links hardware to ongoing services, creating an integrated ecosystem for sleep and respiratory care.

Quarterly Earnings

QuarterDateEPS
Q2 FY27Jan 28, 2027 (est.)—
Q1 FY27Oct 29, 2026$2.91
Q4 FY26Aug 6, 2026$2.95
Q3 FY26Apr 30, 2026$2.86
Q2 FY26Jan 29, 2026$2.81

Stay ahead of RMD earnings

Get reminders ahead of RMD's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500